Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-26 Option Award | 2023-10-30 4:14 pm | 2024-10-26 2033-10-26 | Quoin Pharmaceuticals Ltd. | QNRX | SEMBER MICHAEL T Director | 7,652 | $0 | 7,652 (Direct) | View |
| 2023-10-26 Option Award | 2023-10-30 4:12 pm | 2024-10-26 2033-10-26 | Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer | 51,149 | $0 | 51,149 (Direct) | View |
| 2023-10-26 Option Award | 2023-10-30 4:11 pm | 2024-10-26 2033-10-26 | Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer | 80,965 | $0 | 80,965 (Direct) | View |
| 2023-10-26 Option Award | 2023-10-30 4:10 pm | 2024-10-26 2033-10-26 | Quoin Pharmaceuticals Ltd. | QNRX | Culverwell Anthony James Director | 7,652 | $0 | 7,652 (Direct) | View |
| 2023-10-26 Option Award | 2023-10-30 4:08 pm | 2024-10-26 2033-10-26 | Quoin Pharmaceuticals Ltd. | QNRX | Cooper Joseph Patrick Director | 7,652 | $0 | 7,652 (Direct) | View |
| 2023-10-26 Option Award | 2023-10-30 4:08 pm | 2024-10-26 2033-10-26 | Quoin Pharmaceuticals Ltd. | QNRX | Leong Natalie Ee Mun Director | 7,652 | $0 | 7,652 (Direct) | View |
| 2023-10-26 Option Award | 2023-10-30 4:06 pm | 2024-10-26 2033-10-26 | Quoin Pharmaceuticals Ltd. | QNRX | Carter Denise P. Chief Operating Officer | 80,966 | $0 | 80,966 (Direct) | View |
| 2023-10-26 Option Award | 2023-10-30 4:05 pm | 2024-10-26 2033-10-26 | Quoin Pharmaceuticals Ltd. | QNRX | LANGER DENNIS Director | 7,652 | $0 | 7,652 (Direct) | View |
Ownership | 2023-03-07 7:15 pm | 2023-04-12 2032-04-12 | Quoin Pharmaceuticals Ltd. | QNRX | SEMBER MICHAEL T Director | 0 | $0 | 64,285,600 (Direct) | View |
Ownership(A) | 2023-03-07 7:13 pm | 2023-04-12 2032-04-12 | Quoin Pharmaceuticals Ltd. | QNRX | LANGER DENNIS Director | 0 | $0 | 64,285,600 (Direct) | View |
Ownership(A) | 2023-03-07 7:13 pm | 2023-04-12 2032-04-12 | Quoin Pharmaceuticals Ltd. | QNRX | Cooper Joseph Patrick Director | 0 | $0 | 64,285,600 (Direct) | View |
Ownership(A) | 2023-03-07 7:13 pm | 2023-04-12 2032-04-12 | Quoin Pharmaceuticals Ltd. | QNRX | Culverwell Anthony James Director | 0 | $0 | 64,285,600 (Direct) | View |
Ownership(A) | 2023-03-07 7:12 pm | 2023-04-12 2032-04-12 | Quoin Pharmaceuticals Ltd. | QNRX | Leong Natalie Ee Mun Director | 0 | $0 | 64,285,600 (Direct) | View |
Ownership | 2023-01-03 09:47 am | N/A N/A | Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer | 0 | $0 | 990,051,600 (Direct) | View |
Ownership | 2023-01-03 09:45 am | 2023-04-12 2032-04-12 | Quoin Pharmaceuticals Ltd. | QNRX | Cooper Joseph Patrick Director | 0 | $0 | 64,285,600 (Direct) | View |
Ownership | 2023-01-03 09:43 am | N/A N/A | Quoin Pharmaceuticals Ltd. | QNRX | Carter Denise P. Chief Operating Officer | 0 | $0 | 990,046,600 (Direct) | View |
Ownership | 2023-01-03 09:40 am | 2023-04-12 2032-04-12 | Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer | 0 | $0 | 357,142,800 (Direct) | View |
Ownership | 2023-01-03 09:38 am | N/A N/A | Quoin Pharmaceuticals Ltd. | QNRX | Culverwell Anthony James Director | 0 | $0 | 83,355,600 (Direct) | View |
Ownership | 2023-01-03 09:37 am | N/A N/A | Quoin Pharmaceuticals Ltd. | QNRX | LANGER DENNIS Director | 0 | $0 | 85,290,600 (Direct) | View |
Ownership | 2023-01-03 09:33 am | 2023-04-12 2032-04-12 | Quoin Pharmaceuticals Ltd. | QNRX | Leong Natalie Ee Mun Director | 0 | $0 | 64,285,600 (Direct) | View |